Safe, sterile, multi-purpose
(4) V.Cesarec et al (2013) Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy European Journal of Pharmacology, Volume 701, Issues 13, 15 February 2013, Pages 203-212
This is clinically relevant because obesity itself is associated with numerous health conditions that might influence treatment tolerance, including metabolic syndrome, cardiovascular disease, sleep apnea, and hepatic steatosis
(2012) Evidence to support the use of vildagliptin monotherapy in the treatment of type 2 diabetes mellitus
deficiency impairs redox balance, increases oxidative damage, and alters T3/T4 metabolism
Never freeze lyophilized peptides either, same clumping risk applies